11-01-2022 02:33 PM | Source: Reuters
India's Sun Pharmaceutical Q2 profit rises 11%
Sun Pharmaceutical Industries Ltd, India's largest drugmaker, on Tuesday reported a 10.5% rise in second quarter profit on higher sales in the domestic market.
The company, known for its consumer healthcare products such as Revital vitamins and pain relief medicine Volini, said consolidated net profit for three months ended Sept. 30 was 22.62 billion Indian rupees ($273.75 million), up from 20.47 billion rupees last year.
Analysts, on average, expected the company to report profit of 19.83 billion rupees, according to Refinitiv IBES data.
($1 = 82.6300 Indian rupees)
Latest News
Evening Roundup : A Daily Report on Bullion Energy &...
ITI AMC announces activation of new OPA
India's Blue Star posts jump in Q4 adjusted profit o...
Gautam Adani meets new British envoy to India, wishe...
FIIs stood as net buyers in equities as per May 02 d...
NPCI partners Bank of Namibia to develop UPI-like pa...
Report on power sector equity raises to power up to ...
Motilal Oswal Flexicap Fund Celebrates a Decade of H...
Buy Zinc above 258.50 SL below 256.50tct 261/262 - A...
Blue Star`s FY24 Total Income rises 21.4% to Rs 9685...